Cas no 885521-15-3 (6-Iodo-4-methyl Indole)
6-Iodo-4-methyl Indole Chemical and Physical Properties
Names and Identifiers
-
- 6-Iodo-4-methyl-1H-indole
- 1H-Indole, 6-iodo-4-Methyl-
- DTXSID10646473
- 885521-15-3
- 6-Iodo-4-methyl indole
- 6-Iodo-4-methyl Indole
-
- MDL: MFCD07781483
- Inchi: 1S/C9H8IN/c1-6-4-7(10)5-9-8(6)2-3-11-9/h2-5,11H,1H3
- InChI Key: ZYVXWSCWOMJDHK-UHFFFAOYSA-N
- SMILES: IC1C=C(C)C2C=CNC=2C=1
Computed Properties
- Exact Mass: 256.97015Da
- Monoisotopic Mass: 256.97015Da
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 0
- Heavy Atom Count: 11
- Rotatable Bond Count: 0
- Complexity: 148
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.1
- Topological Polar Surface Area: 15.8?2
6-Iodo-4-methyl Indole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | I737853-1mg |
6-Iodo-4-methyl Indole |
885521-15-3 | 1mg |
$ 50.00 | 2022-06-04 | ||
| TRC | I737853-2mg |
6-Iodo-4-methyl Indole |
885521-15-3 | 2mg |
$ 65.00 | 2022-06-04 | ||
| TRC | I737853-10mg |
6-Iodo-4-methyl Indole |
885521-15-3 | 10mg |
$ 160.00 | 2022-06-04 | ||
| eNovation Chemicals LLC | Y0997582-5g |
6-Iodo-4-methylindole |
885521-15-3 | 95% | 5g |
$1800 | 2024-08-02 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1618781-100mg |
6-Iodo-4-methyl-1H-indole |
885521-15-3 | 98% | 100mg |
¥2975.00 | 2024-04-27 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1618781-1g |
6-Iodo-4-methyl-1H-indole |
885521-15-3 | 98% | 1g |
¥8918.00 | 2024-04-27 | |
| eNovation Chemicals LLC | Y0997582-5g |
6-iodo-4-methylindole |
885521-15-3 | 95% | 5g |
$2500 | 2025-02-20 | |
| eNovation Chemicals LLC | Y0997582-5g |
6-iodo-4-methylindole |
885521-15-3 | 95% | 5g |
$2500 | 2025-02-28 |
6-Iodo-4-methyl Indole Related Literature
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
Additional information on 6-Iodo-4-methyl Indole
Research Brief on 6-Iodo-4-methyl Indole (CAS: 885521-15-3) in Chemical Biology and Pharmaceutical Applications
6-Iodo-4-methyl Indole (CAS: 885521-15-3) is a halogenated indole derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including kinase inhibitors, antimicrobial agents, and fluorescent probes. Recent studies have highlighted its potential in drug discovery, particularly in the development of targeted therapies for cancer and infectious diseases.
A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 6-Iodo-4-methyl Indole as a building block for the synthesis of novel indole-based kinase inhibitors. The researchers utilized palladium-catalyzed cross-coupling reactions to derivatize the compound, yielding a library of potent and selective inhibitors against specific oncogenic kinases. The study reported promising in vitro and in vivo results, with several derivatives exhibiting nanomolar inhibitory activity and favorable pharmacokinetic properties.
In the field of antimicrobial research, 6-Iodo-4-methyl Indole has been investigated for its role in the development of new antibacterial agents. A recent publication in Bioorganic & Medicinal Chemistry Letters described the synthesis of indole-containing compounds derived from 6-Iodo-4-methyl Indole, which showed potent activity against multidrug-resistant bacterial strains. The study emphasized the compound's ability to disrupt bacterial biofilm formation, a critical factor in antibiotic resistance.
Another emerging application of 6-Iodo-4-methyl Indole is in the development of fluorescent probes for biological imaging. Researchers have exploited the compound's indole core to design probes that can selectively bind to specific cellular targets, enabling real-time visualization of biological processes. A 2022 study in Chemical Communications reported the successful use of a 6-Iodo-4-methyl Indole-derived probe for imaging protein-protein interactions in live cells, opening new avenues for studying intracellular signaling pathways.
The synthesis and scale-up of 6-Iodo-4-methyl Indole have also seen advancements. Recent patents and technical reports describe improved synthetic routes that enhance yield and purity while reducing environmental impact. These developments are critical for ensuring the compound's availability for both research and potential commercial applications.
In conclusion, 6-Iodo-4-methyl Indole (CAS: 885521-15-3) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its versatility in drug discovery, antimicrobial development, and bioimaging applications underscores its importance in the field. Ongoing research is expected to further expand its utility and uncover new therapeutic possibilities.
885521-15-3 (6-Iodo-4-methyl Indole) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)